665 related articles for article (PubMed ID: 12626531)
1. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo.
Kleindienst P; Brocker T
J Immunol; 2003 Mar; 170(6):2817-23. PubMed ID: 12626531
[TBL] [Abstract][Full Text] [Related]
2. Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model.
Lambrecht BN; Pauwels RA; Fazekas De St Groth B
J Immunol; 2000 Mar; 164(6):2937-46. PubMed ID: 10706680
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
4. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells.
Tanaka Y; Koido S; Ohana M; Liu C; Gong J
J Immunol; 2005 Feb; 174(3):1274-80. PubMed ID: 15661883
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
6. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
[TBL] [Abstract][Full Text] [Related]
7. Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells.
Gerner MY; Mescher MF
J Immunol; 2009 Mar; 182(5):2726-37. PubMed ID: 19234167
[TBL] [Abstract][Full Text] [Related]
8. B lymphocytes participate in cross-presentation of antigen following gene gun vaccination.
Hon H; Oran A; Brocker T; Jacob J
J Immunol; 2005 May; 174(9):5233-42. PubMed ID: 15843519
[TBL] [Abstract][Full Text] [Related]
9. Mucosally delivered dendritic cells activate T cells independently of IL-12 and endogenous APCs.
McCormick S; Santosuosso M; Small CL; Shaler CR; Zhang X; Jeyanathan M; Mu J; Takenaka S; Ngai P; Gauldie J; Wan Y; Xing Z
J Immunol; 2008 Aug; 181(4):2356-67. PubMed ID: 18684925
[TBL] [Abstract][Full Text] [Related]
10. In situ analysis reveals physical interactions between CD11b+ dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen.
Ingulli E; Ulman DR; Lucido MM; Jenkins MK
J Immunol; 2002 Sep; 169(5):2247-52. PubMed ID: 12193689
[TBL] [Abstract][Full Text] [Related]
11. Killing of naive T cells by CD95L-transfected dendritic cells (DC): in vivo study using killer DC-DC hybrids and CD4(+) T cells from DO11.10 mice.
Kusuhara M; Matsue K; Edelbaum D; Loftus J; Takashima A; Matsue H
Eur J Immunol; 2002 Apr; 32(4):1035-43. PubMed ID: 11920570
[TBL] [Abstract][Full Text] [Related]
12. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
13. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions.
Zou T; Caton AJ; Koretzky GA; Kambayashi T
J Immunol; 2010 Sep; 185(5):2790-9. PubMed ID: 20686126
[TBL] [Abstract][Full Text] [Related]
15. A novel dendritic cell-induced model of erosive inflammatory arthritis: distinct roles for dendritic cells in T cell activation and induction of local inflammation.
Leung BP; Conacher M; Hunter D; McInnes IB; Liew FY; Brewer JM
J Immunol; 2002 Dec; 169(12):7071-7. PubMed ID: 12471143
[TBL] [Abstract][Full Text] [Related]
16. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
Stober D; Jomantaite I; Schirmbeck R; Reimann J
J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
[TBL] [Abstract][Full Text] [Related]
17. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells.
Schnell S; Young JW; Houghton AN; Sadelain M
J Immunol; 2000 Feb; 164(3):1243-50. PubMed ID: 10640737
[TBL] [Abstract][Full Text] [Related]
18. Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway.
You Z; Huang XF; Hester J; Rollins L; Rooney C; Chen SY
J Immunol; 2000 Oct; 165(8):4581-91. PubMed ID: 11035100
[TBL] [Abstract][Full Text] [Related]
19. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis.
Dittel BN; Visintin I; Merchant RM; Janeway CA
J Immunol; 1999 Jul; 163(1):32-9. PubMed ID: 10384096
[TBL] [Abstract][Full Text] [Related]
20. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
